CLDN11 and vibrio infectious disease: This and subsequent evaluations should include assessment of immune responses associated with protection against cholera, including OSP-LPS-specific responses in serum, OSP-LPS-specific responses in mucosal samples (antibody secretory cell analysis with mucosal homing markers), and OSP-LPS memory B cell responses.